This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Academia Sinica, Taipei Medical University. Active years: 2016.
Company Filing History:
1 out of 726 
1 out of 146 
Years Active: 2016
Title: Ken-Fen Lu: Innovator in Monoclonal Antibodies for Endometriosis Detection
Introduction
Ken-Fen Lu is a distinguished inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of endometriosis. His innovative work has led to the development of specific monoclonal antibodies that can aid in diagnosing this condition.
Latest Patents
Ken-Fen Lu holds a patent for "Specific A1AT monoclonal antibodies for detection of endometriosis." This patent describes monoclonal antibodies with a high binding affinity to isoforms of alpha 1-antitrypsin (A1AT). The invention includes hybridoma cells producing these antibodies and their applications in diagnosing and detecting endometriosis from serum samples of subjects suspected of having the condition or undergoing health examinations. He has 1 patent to his name.
Career Highlights
Throughout his career, Ken-Fen Lu has been associated with prominent institutions such as Taipei Medical University and Academia Sinica. His work in these organizations has been pivotal in advancing research and development in medical diagnostics.
Collaborations
Ken-Fen Lu has collaborated with notable colleagues, including Wei-Chung Yang and Hwei-Jiung Wang. Their joint efforts have contributed to the success of his research and innovations.
Conclusion
Ken-Fen Lu's contributions to the field of medical diagnostics, particularly through his patented monoclonal antibodies, highlight his role as an innovator in the detection of endometriosis. His work continues to impact the medical community positively.